Delivery Order SPE2DB22D1103-SPE2DB24FTKE9

Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $5.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $12,058 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the ROTARIX vaccine oral syringe 1.5 mL, with a completion date of May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the delivery of ROTARIX VACCINE ORAL SYRINGE 1.5ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,929.56 and runs through November 4, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and expiring in November 2026. The IDC enables the company to provide a...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $15,494.25 firm fixed price delivery order contract to provide Rotarix vaccine oral syringes (1.5 mL). This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ROTARIX VACCINE ORAL SYRINGE 1.5ML. The contract has a potential value of $13,074.67 and a completion date of January 31, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the ROTARIX vaccine oral syringe 1.5mL to the Defense Logistics Agency (DLA). The award has a ceiling value of $9,642.64 and an ultimate completion date of June 6, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ROTARIX VACCINE ORAL SYRINGE 1.5ML to the Defense Logistics Agency (DLA). The award, valued at $5,570.55, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a for-profit pharmaceutical distribution company, to provide the ROTARIX vaccine oral syringe 1.5ML to the U.S. government. The contract is a firm fixed price delivery order with a ceiling value of $10,435.47 and a performance period through March 19, 2024. Amerisourcebergen Drug Corporation, through its Corporate Office division located in Conshohocken,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,464.80, is for the supply of the ROTARIX vaccine oral syringe 1.5 mL. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Rotarix vaccine oral syringes (1.5 ml) to the U.S. government. The award, valued at $5,489.34, is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of May 30, 2024 and was awarded on May 29, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $40,202.40 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,161,303 units of the ROTARIX vaccine oral syringe, 1.5 mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTKE9
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the ROTARIX vaccine oral syringe 1.5 mL product. The contract has a ceiling value of $5,418.15 and a period of performance through May 7, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award does not have a set-aside designation.

Generated 8/5/24, 9:13 AM